Sökning: WFRF:(Sundberg Olle) > (2020-2024) > Multiplexing DNA me...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06189naa a2200601 4500 | |
001 | oai:DiVA.org:uu-423036 | |
003 | SwePub | |
008 | 201021s2020 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4230362 URI |
024 | 7 | a https://doi.org/10.1172/jci.insight.1365792 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Neiman, Danielu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
245 | 1 0 | a Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells |
264 | c 2020-07-23 | |
264 | 1 | b American Society for Clinical Investigation,c 2020 |
338 | a print2 rdacarrier | |
500 | a Wos title: Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic beta cells | |
520 | a It has been proposed that unmethylated insulin promoter fragments in plasma derive exclusively from β cells, reflect their recent demise, and can be used to assess β cell damage in type 1 diabetes. Herein we describe an ultrasensitive assay for detection of a β cell–specific DNA methylation signature, by simultaneous assessment of 6 DNA methylation markers, that identifies β cell DNA in mixtures containing as little as 0.03% β cell DNA (less than 1 β cell genome equivalent). Based on this assay, plasma from nondiabetic individuals (N = 218, aged 4–78 years) contained on average only 1 β cell genome equivalent/mL. As expected, cell-free DNA (cfDNA) from β cells was significantly elevated in islet transplant recipients shortly after transplantation. We also detected β cell cfDNA in a patient with KATP congenital hyperinsulinism, in which substantial β cell turnover is thought to occur. Strikingly, in contrast to previous reports, we observed no elevation of β cell–derived cfDNA in autoantibody-positive subjects at risk for type 1 diabetes (N = 32), individuals with recent-onset type 1 diabetes (<4 months, N = 92), or those with long-standing disease (>4 months, N = 38). We discuss the utility of sensitive β cell cfDNA analysis and potential explanations for the lack of a β cell cfDNA signal in type 1 diabetes. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
700 | 1 | a Gillis, Davidu Hadassah Hebrew Univ, Endocrine Unit, Dept Pediat, Med Ctr, Jerusalem, Israel.4 aut |
700 | 1 | a Piyanzin, Sheinau Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Cohen, Danielu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Fridlich, Oriu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Moss, Joshuau Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Zick, Aviadu Hadassah Hebrew Univ, Sharett Inst Oncol, Med Ctr, Jerusalem, Israel.4 aut |
700 | 1 | a Oron, Talu Schneider Childrens Med Ctr Israel, Inst Endocrinol & Diabet, Petah Tiqwa, Israel.4 aut |
700 | 1 | a Sundberg, Fridau Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Gothenburg, Sweden.4 aut |
700 | 1 | a Forsander, Gunu Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Gothenburg, Sweden.4 aut |
700 | 1 | a Skog, Oskar,c Docent, PhD,d 1981-u Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)ossko535 |
700 | 1 | a Korsgren, Olleu Uppsala universitet,Klinisk immunologi4 aut0 (Swepub:uu)ollekors |
700 | 1 | a Levy-Khademi, Florisu Shaare Zedek Med Ctr, Dept Pediat, Jerusalem, Israel.4 aut |
700 | 1 | a Arbel, Danu Hadassah Hebrew Univ, Med Ctr, Pediat Surg, Jerusalem, Israel.4 aut |
700 | 1 | a Hashavia, Saaru Hadassah Hebrew Univ, Med Ctr, Pediat Emergency, Jerusalem, Israel.4 aut |
700 | 1 | a Shapiro, A. M. Jamesu Univ Alberta, Li Ka Shing Ctr Hlth Res Innovat, Edmonton, AB, Canada.4 aut |
700 | 1 | a Speake, Cateu Benaroya Res Inst, Diabet Program, Seattle, WA USA.4 aut |
700 | 1 | a Greenbaum, Carlau Benaroya Res Inst, Diabet Program, Seattle, WA USA.4 aut |
700 | 1 | a Hosford, Jenniferu Univ Florida, Diabet Inst, Dept Pediat, Gainesville, FL 32610 USA.;Univ Florida, Diabet Inst, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.4 aut |
700 | 1 | a Posgai, Amandau Univ Florida, Coll Med, Gainesville, FL 32610 USA.4 aut |
700 | 1 | a Atkinson, Mark A.u Univ Florida, Diabet Inst, Dept Pediat, Gainesville, FL 32610 USA.;Univ Florida, Diabet Inst, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.;Univ Florida, Coll Med, Gainesville, FL 32610 USA.4 aut |
700 | 1 | a Glaser, Benjaminu Hadassah Hebrew Univ, Dept Internal Med, Endocrinol & Metab Serv, Med Ctr, Jerusalem, Israel.4 aut |
700 | 1 | a Schatz, Desmond A.u Univ Florida, Diabet Inst, Dept Pediat, Gainesville, FL 32610 USA.;Univ Florida, Diabet Inst, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.4 aut |
700 | 1 | a Shemer, Ruthu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
700 | 1 | a Dor, Yuvalu Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.4 aut |
710 | 2 | a Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Hadassah Med Sch, Jerusalem, Israel.b Hadassah Hebrew Univ, Endocrine Unit, Dept Pediat, Med Ctr, Jerusalem, Israel.4 org |
773 | 0 | t JCI Insightd : American Society for Clinical Investigationg 5:14q 5:14x 2379-3708 |
856 | 4 | u http://insight.jci.org/articles/view/136579/files/pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-423036 |
856 | 4 8 | u https://doi.org/10.1172/jci.insight.136579 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.